ArticleScientific reports2025
Prevalence and associated factors of multi-drug resistant bacteria among different clinical specimens at wad Medani, Sudan: a four-year, cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Genomic and phenotypic characterization of Klebsiella pneumoniae phage KP Ø1: a novel lytic Slopekvirus targeting uropathogenic multidrug-resistant Klebsiella pneumoniae.Scientific reports · 2026Article
- Antimicrobial resistance surveillance of clinical bacterial isolates at Maryamana private hospital, Erbil-Iraq (2023-2025): antibiogram data and multidrug-resistant (MDR)/extensively drug-resistant (XDR)/pandrug-resistant (PDR) classification.Iranian journal of microbiology · 2026Article
- Structural modeling and docking analysis of canonical and novel resistance-associated missense mutations in Sudanese Escherichia coli.Scientific reports · 2026Article
- Article
- Incidence and Antibiotic Susceptibility of Gram-Negative Bacteria Associated With Chest Infections in Intensive Care Unit Patients From a Selected Hospital in the Kingdom of Saudi Arabia.BioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multi-drug resistant organisms (MDROs) are a global health concern. Therefore, the aim of the study is to evaluate the prevalence of MDROs and associated factors among different clinical specimens. This was a retrospective cross-sectional study, conducted between January 2020 to October 2023 using recorded laboratory data of culture and drug sensitivity from the Pathology Center for Diagnosis and Research, University of Gezira, Wad Medani City, Sudan. Among the 1766 investigated clinical samples, 1255 (71.1%) were from female. The overall MDROs prevalence was 694 (39.3%). Blood samples 45(52.3%) and wound swabs 191(41.2%) had the most MDROs. Staphylococcus aureus (S. aureus) and Proteus spp. 42(75%) had the highest MDR among the gram-positive bacteria (GPB) and the gram-negative bacteria (GNB) respectively. A significant association was observed between cerebrospinal fluid (CSF) and urine samples with the presence of MDROs. This study revealed a moderate prevalence of MDROs. Which is more prevalent in blood samples, wound swabs and in GNB. S. aureus and Proteus spp. had the greatest MDR among the GPB, and GNB, respectively. CSF and urine samples were associated with the presence of MDROs. Implementing these findings enables the development of strategies to prevent AMR in Sudan and other comparable low-resource environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.